{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:04:04Z","timestamp":1794539044207,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06089-1","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:47:32Z","timestamp":1775080052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aiolos and Eos drive distinct human TH17 functional states"],"prefix":"10.1007","volume":"83","author":[{"given":"Silvia","family":"Cerboni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Mohammadnezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandramouli","family":"Budida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gaggero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Dulong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Mezger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Israelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Volkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva F.","family":"Caceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malo","family":"Leprohon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba Shekarkar","family":"Azgomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana","family":"Salemio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Firth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Wigge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Grindebacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystal","family":"Paulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Morschhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon","family":"Manier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Kazemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Laurence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"H\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Gehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Tarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3426-371X","authenticated-orcid":false,"given":"Suman","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"6089_CR1","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/eji.201242741","volume":"42","author":"F Sallusto","year":"2012","unstructured":"Sallusto F, Zielinski CE, Lanzavecchia A (2012) Human Th17 subsets. Eur J Immunol 42:2215\u20132220","journal-title":"Eur J Immunol"},{"key":"6089_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.12688\/f1000research.6116.1","volume":"4","author":"Y Lee","year":"2015","unstructured":"Lee Y, Kuchroo V (2015) Defining the functional states of Th17 cells. F1000Res 4:132","journal-title":"F1000Res"},{"issue":"Suppl 3","key":"6089_CR3","doi-asserted-by":"publisher","first-page":"iii26","DOI":"10.1136\/ard.2008.098004","volume":"67","author":"M Oukka","year":"2008","unstructured":"Oukka M (2008) Th17 cells in immunity and autoimmunity. Ann Rheum Dis 67(Suppl 3):iii26-29","journal-title":"Ann Rheum Dis"},{"key":"6089_CR4","volume":"2014","author":"JF Zambrano-Zaragoza","year":"2014","unstructured":"Zambrano-Zaragoza JF, Romo-Martinez EJ, Duran-Avelar MJ, Garcia-Magallanes N, Vibanco-Perez N (2014) Th17 cells in autoimmune and infectious diseases. Int J Inflam 2014:651503","journal-title":"Int J Inflam"},{"key":"6089_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","volume":"114","author":"I Kryczek","year":"2009","unstructured":"Kryczek I et al (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114:1141\u20131149","journal-title":"Blood"},{"key":"6089_CR6","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jhep.2008.12.033","volume":"50","author":"JP Zhang","year":"2009","unstructured":"Zhang JP et al (2009) Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 50:980\u2013989","journal-title":"J Hepatol"},{"key":"6089_CR7","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.4049\/jimmunol.0902813","volume":"184","author":"X Su","year":"2010","unstructured":"Su X et al (2010) Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 184:1630\u20131641","journal-title":"J Immunol"},{"key":"6089_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nri2742","volume":"10","author":"W Zou","year":"2010","unstructured":"Zou W, Restifo NP (2010) T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 10:248\u2013256","journal-title":"Nat Rev Immunol"},{"key":"6089_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","volume":"26","author":"A Laurence","year":"2007","unstructured":"Laurence A et al (2007) Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26:371\u2013381","journal-title":"Immunity"},{"key":"6089_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni1467","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV et al (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8:639\u2013646","journal-title":"Nat Immunol"},{"key":"6089_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature10957","volume":"484","author":"CE Zielinski","year":"2012","unstructured":"Zielinski CE et al (2012) Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484:514\u2013518","journal-title":"Nature"},{"key":"6089_CR12","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ni.1915","volume":"11","author":"R Gandhi","year":"2010","unstructured":"Gandhi R et al (2010) Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat Immunol 11:846\u2013853","journal-title":"Nat Immunol"},{"key":"6089_CR13","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41467-017-01571-8","volume":"8","author":"D Hu","year":"2017","unstructured":"Hu D et al (2017) Transcriptional signature of human pro-inflammatory T(H)17 cells identifies reduced IL10 gene expression in multiple sclerosis. Nat Commun 8:1600","journal-title":"Nat Commun"},{"key":"6089_CR14","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s41590-018-0200-5","volume":"19","author":"D Aschenbrenner","year":"2018","unstructured":"Aschenbrenner D et al (2018) An immunoregulatory and tissue-residency program modulated by c-MAF in human T(H)17 cells. Nat Immunol 19:1126\u20131136","journal-title":"Nat Immunol"},{"key":"6089_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102544","volume":"114","author":"AS Gokhale","year":"2020","unstructured":"Gokhale AS, Gangaplara A, Lopez-Occasio M, Thornton AM, Shevach EM (2020) Corrigendum to \u201cSelective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity\u201d [J. Autoimmun. 105C (<pubYear>2019<\/pubYear>) 102300]. J Autoimmun 114:102544","journal-title":"J Autoimmun"},{"key":"6089_CR16","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1038\/ncomms4199","volume":"5","author":"HG Evans","year":"2014","unstructured":"Evans HG et al (2014) TNF-alpha blockade induces IL-10 expression in human CD4+ T cells. Nat Commun 5:3199","journal-title":"Nat Commun"},{"key":"6089_CR17","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee Y et al (2012) Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 13:991\u2013999","journal-title":"Nat Immunol"},{"key":"6089_CR18","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8:942\u2013949","journal-title":"Nat Immunol"},{"key":"6089_CR19","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1084\/jem.20070663","volume":"204","author":"F Annunziato","year":"2007","unstructured":"Annunziato F et al (2007) Phenotypic and functional features of human Th17 cells. J Exp Med 204:1849\u20131861","journal-title":"J Exp Med"},{"key":"6089_CR20","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1002\/eji.201242648","volume":"42","author":"L Maggi","year":"2012","unstructured":"Maggi L et al (2012) Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells. Eur J Immunol 42:3180\u20133188","journal-title":"Eur J Immunol"},{"key":"6089_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.immuni.2014.01.002","volume":"40","author":"Y Wang","year":"2014","unstructured":"Wang Y et al (2014) The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-gamma-producing T helper 17 cells. Immunity 40:355\u2013366","journal-title":"Immunity"},{"key":"6089_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008706","volume":"6","author":"R Noster","year":"2014","unstructured":"Noster R et al (2014) IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells. Sci Transl Med 6:241ra280","journal-title":"Sci Transl Med"},{"key":"6089_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02148","volume":"11","author":"T Arshad","year":"2020","unstructured":"Arshad T, Mansur F, Palek R, Manzoor S, Liska V (2020) A double edged sword role of interleukin-22 in wound healing and tissue regeneration. Front Immunol 11:2148","journal-title":"Front Immunol"},{"key":"6089_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S1074-7613(00)80034-5","volume":"10","author":"J Kim","year":"1999","unstructured":"Kim J et al (1999) Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10:345\u2013355","journal-title":"Immunity"},{"key":"6089_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01299","volume":"10","author":"MD Powell","year":"2019","unstructured":"Powell MD, Read KA, Sreekumar BK, Oestreich KJ (2019) Ikaros zinc finger transcription factors: regulators of cytokine signaling pathways and CD4(+) T helper cell differentiation. Front Immunol 10:1299","journal-title":"Front Immunol"},{"key":"6089_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/ni.2363","volume":"13","author":"FJ Quintana","year":"2012","unstructured":"Quintana FJ et al (2012) Aiolos promotes TH17 differentiation by directly silencing Il2 expression. Nat Immunol 13:770\u2013777","journal-title":"Nat Immunol"},{"key":"6089_CR27","doi-asserted-by":"crossref","unstructured":"Bernardi C et al (2021) CD4(+) T cells require Ikaros to inhibit their differentiation toward a pathogenic cell fate. Proc Natl Acad Sci USA 118","DOI":"10.1073\/pnas.2023172118"},{"key":"6089_CR28","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.4049\/jimmunol.0901284","volume":"183","author":"SE Umetsu","year":"2009","unstructured":"Umetsu SE, Winandy S (2009) Ikaros is a regulator of Il10 expression in CD4+ T cells. J Immunol 183:5518\u20135525","journal-title":"J Immunol"},{"key":"6089_CR29","doi-asserted-by":"publisher","first-page":"12163","DOI":"10.1073\/pnas.1322807111","volume":"111","author":"P Soroosh","year":"2014","unstructured":"Soroosh P et al (2014) Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation. Proc Natl Acad Sci USA 111:12163\u201312168","journal-title":"Proc Natl Acad Sci USA"},{"key":"6089_CR30","doi-asserted-by":"publisher","first-page":"6516","DOI":"10.1158\/0008-5472.CAN-09-4566","volume":"70","author":"Y Cheng","year":"2010","unstructured":"Cheng Y et al (2010) KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas. Cancer Res 70:6516\u20136526","journal-title":"Cancer Res"},{"key":"6089_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY et al (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14:128","journal-title":"BMC Bioinformatics"},{"key":"6089_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13062-015-0045-x","volume":"10","author":"MJ Stubbington","year":"2015","unstructured":"Stubbington MJ et al (2015) An atlas of mouse CD4(+) T cell transcriptomes. Biol Direct 10:14","journal-title":"Biol Direct"},{"key":"6089_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","volume":"343","author":"J Kronke","year":"2014","unstructured":"Kronke J et al (2014) Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343:301\u2013305","journal-title":"Science"},{"key":"6089_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1126\/science.1244917","volume":"343","author":"G Lu","year":"2014","unstructured":"Lu G et al (2014) The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343:305\u2013309","journal-title":"Science"},{"key":"6089_CR35","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1182\/bloodadvances.2020003774","volume":"5","author":"C Menard","year":"2021","unstructured":"Menard C et al (2021) Lenalidomide triggers T-cell effector functions in vivo in patients with follicular lymphoma. Blood Adv 5:2063\u20132074","journal-title":"Blood Adv"},{"key":"6089_CR36","doi-asserted-by":"crossref","unstructured":"Bauche D et al (2020) IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis. Sci Immunol 5","DOI":"10.1126\/sciimmunol.aav1080"},{"key":"6089_CR37","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.immuni.2012.02.017","volume":"36","author":"JX Lin","year":"2012","unstructured":"Lin JX et al (2012) Critical role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. Immunity 36:586\u2013599","journal-title":"Immunity"},{"key":"6089_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1172\/JCI37865","volume":"119","author":"D Bending","year":"2009","unstructured":"Bending D et al (2009) Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD\/SCID recipient mice. J Clin Invest 119:565\u2013572","journal-title":"J Clin Invest"},{"key":"6089_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4049\/jimmunol.1500627","volume":"195","author":"SA Rieder","year":"2015","unstructured":"Rieder SA et al (2015) Eos is redundant for regulatory T cell function but plays an important role in IL-2 and Th17 production by CD4+ conventional T cells. J Immunol 195:553\u2013563","journal-title":"J Immunol"},{"key":"6089_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2182619","volume":"34","author":"G Mioso","year":"2023","unstructured":"Mioso G, Gnesotto L, Russo I, Piaserico S, Alaibac M (2023) Exacerbation of psoriasis induced by lenalidomide in a patient with multiple myeloma. J Dermatolog Treat 34:2182619","journal-title":"J Dermatolog Treat"},{"key":"6089_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12965","volume":"40","author":"D De Novellis","year":"2024","unstructured":"De Novellis D et al (2024) Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B. Photodermatol Photoimmunol Photomed 40:e12965","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"6089_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14293","volume":"26","author":"R Chandar","year":"2022","unstructured":"Chandar R et al (2022) Post-transplant strategies to improve relapse-free survival in childhood leukemia: whole blood donor lymphocyte infusions and lenalidomide for inducing graft-versus-leukemia effect. Pediatr Transplant 26:e14293","journal-title":"Pediatr Transplant"},{"key":"6089_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12185-023-03602-1","volume":"118","author":"K Kawamura","year":"2023","unstructured":"Kawamura K (2023) Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma. Int J Hematol 118:193\u2013200","journal-title":"Int J Hematol"},{"key":"6089_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jmcb\/mjr042","volume":"4","author":"AG Besnard","year":"2012","unstructured":"Besnard AG et al (2012) Inflammasome-IL-1-Th17 response in allergic lung inflammation. J Mol Cell Biol 4:3\u201310","journal-title":"J Mol Cell Biol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06089-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06089-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06089-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T02:02:22Z","timestamp":1775700142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06089-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6089"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06089-1","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Healthy donors were recruited from AstraZeneca volunteers and all samples were taken following appropriate blood collection guidelines. All blood donor volunteers signed Informed Consent Form and donation was approved by AstraZeneca\u2019s Human Biological Sample Governance Framwork and local Ethic committee Dnr:2019\u201303307 (033\u201310). This research utilized PBMC samples from follicular lymphoma (FL) patients who were enrolled in the GALEN clinical trial (NCT01582776). The research protocol was conducted under French legal guidelines and was approved by the local ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided informed consent for the use of their biological samples in research and publication of results in anonymized form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.C., K.A., R.B., S.L., Y.C. and S.V. were fellows of the AstraZeneca R&D postdoc program. S.C., K.A., R.B., A.M., E.I., P.V., S.L., E.F.C., Y.C., S.V., M.F., L.W., H.G., M.M., M.H. and U.G. are or were employees of AstraZeneca and may own stock or stock options. U.G. is currently employed by Novartis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"199"}}